| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.02B | 42.28B | 30.85B | 28.02B | 27.08B | 37.50B |
| Gross Profit | 25.61B | 35.76B | 21.02B | 17.22B | 12.35B | 21.20B |
| EBITDA | 15.04B | 19.50B | 17.84B | 17.91B | 17.63B | 21.00B |
| Net Income | 11.20B | 9.20B | 7.22B | 7.03B | 7.52B | 10.24B |
Balance Sheet | ||||||
| Total Assets | 777.01B | 677.11B | 566.42B | 522.75B | 509.21B | 452.79B |
| Cash, Cash Equivalents and Short-Term Investments | 48.17B | 324.92B | 327.88B | 329.95B | 312.98B | 256.58B |
| Total Debt | 401.90B | 364.85B | 168.50B | 142.52B | 124.45B | 125.39B |
| Total Liabilities | 690.97B | 594.06B | 459.90B | 425.23B | 415.91B | 372.79B |
| Stockholders Equity | 85.99B | 82.99B | 106.47B | 97.48B | 93.25B | 79.82B |
Cash Flow | ||||||
| Free Cash Flow | 32.47B | -12.67B | 526.03M | -11.20B | 23.73B | 10.50B |
| Operating Cash Flow | 81.41B | -12.15B | 1.06B | -10.13B | 24.28B | 11.12B |
| Investing Cash Flow | -22.24B | -18.55B | -13.32B | -2.65B | -21.24B | 1.80B |
| Financing Cash Flow | 43.72B | 19.96B | 22.63B | 10.84B | 134.81M | 12.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$151.67B | 5.14 | 10.09% | 0.97% | 8.40% | 78.28% | |
69 Neutral | HK$296.30B | 8.17 | 6.85% | 2.75% | 91.20% | 30.16% | |
68 Neutral | HK$179.48B | 4.86 | 10.70% | 2.80% | 2.39% | 46.72% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$436.32B | 7.80 | 11.64% | 2.05% | 48.94% | 36.64% | |
67 Neutral | HK$156.03B | 7.74 | 10.10% | 3.83% | 38.36% | 19.98% | |
63 Neutral | HK$180.83B | 6.38 | 9.27% | 2.92% | 28.52% | 6.24% |